Stockscreener 앱 받기
8.14
0.97%
-0.08
시간 외 거래:
8.12
-0.02
-0.25%
전일 마감가:
$8.22
열려 있는:
$8.29
하루 거래량:
61,069
Relative Volume:
0.29
시가총액:
$763.19M
수익:
$106.66M
순이익/손실:
$15.16M
주가수익비율:
87.06
EPS:
0.0935
순현금흐름:
$6.37M
1주 성능:
+13.21%
1개월 성능:
+13.69%
6개월 성능:
-32.05%
1년 성능:
-23.78%
1일 변동 폭
$8.00
$8.29
1주일 범위
$6.62
$8.30
52주 변동 폭
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
명칭
Gyre Therapeutics Inc
전화
(619) 949-3681
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
8.14 | 746.60M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-11 | 개시 | Noble Capital Markets | Outperform |
| 2021-04-29 | 재개 | Stephens | Overweight |
| 2021-02-10 | 개시 | Piper Sandler | Overweight |
| 2020-05-21 | 개시 | Raymond James | Outperform |
| 2019-01-04 | 개시 | Oppenheimer | Outperform |
| 2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 개시 | Chardan Capital Markets | Buy |
| 2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
| 2016-06-30 | 개시 | Rodman & Renshaw | Buy |
모두보기
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
How moving averages guide Gyre Therapeutics Inc. trading2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Is Gyre Therapeutics Inc. reversing from oversold territoryJuly 2025 Volume & Expert Approved Momentum Ideas - Newser
Understanding Gyre Therapeutics Inc.’s price movement2025 Trading Volume Trends & Reliable Price Action Trade Plans - Newser
How to build a custom watchlist for Gyre Therapeutics Inc.Gold Moves & Growth Focused Stock Pick Reports - Newser
Using RSI to spot recovery in Gyre Therapeutics Inc.Analyst Upgrade & Risk Controlled Daily Trade Plans - Newser
Using AI based signals to follow Gyre Therapeutics Inc.Product Launch & Fast Exit and Entry Strategy Plans - Newser
Gyre Therapeutics Inc. stock trendline breakdownJuly 2025 Setups & Trade Opportunity Analysis Reports - Newser
Can Gyre Therapeutics Inc. be recession proofEarnings Overview Report & Low Risk High Win Rate Stock Picks - thegnnews.com
What Technical Tools Say About Gyre Therapeutics Inc. RecoveryQuarterly Performance Summary & Weekly Top Gainers Alerts - metal.it
Published on: 2025-08-16 06:42:22 - Newser
Is Gyre Therapeutics Inc. meeting your algorithmic filter criteriaMarket Growth Report & Community Verified Trade Alerts - Newser
Can Gyre Therapeutics Inc. recover in the next quarterQuarterly Profit Summary & Reliable Trade Execution Plans - Newser
Is Gyre Therapeutics Inc. a defensive stockPortfolio Risk Summary & Free Real-Time Volume Trigger Notifications - thegnnews.com
Price momentum metrics for Gyre Therapeutics Inc. explainedMarket Performance Summary & Daily Entry Point Alerts - Newser
How to use a screener to detect Gyre Therapeutics Inc. breakoutsEarnings Risk Report & Detailed Earnings Play Strategies - Newser
Tools to assess Gyre Therapeutics Inc.’s risk profileWeekly Trade Review & Daily Chart Pattern Signals - Newser
When is the best time to exit Gyre Therapeutics Inc.Portfolio Risk Report & Comprehensive Market Scan Insights - Newser
What makes Gyre Therapeutics Inc. stock price move sharplyQuarterly Trade Summary & High Win Rate Trade Tips - Newser
Published on: 2025-08-15 14:47:47 - Newser
News impact scoring models applied to Gyre Therapeutics Inc.Earnings Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
Gyre Therapeutics Reports Q2 2025 Earnings and Strategic Updates - TipRanks
Using flow based indicators on Gyre Therapeutics Inc.Swing Trade & Expert Curated Trade Setups - Newser
What Is The Outlook For Bicara Therapeutics Inc (NASDAQ: BCAX) Like For Short-Term? - stocksregister.com
US Undiscovered Gems 3 Promising Small Caps with Strong Potential - simplywall.st
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Down on Disappointing Earnings - Defense World
Gyre Therapeutics Inc. stock trend outlook and recovery pathWatchlist Summary for Active Day Traders - Newser
H.C. Wainwright Initiates a Buy Rating on Gyre Therapeutics (GYRE) - The Globe and Mail
Gyre Therapeutics Misses Estimates And Swaps In A New CEO - Finimize
Gyre Therapeutics Inc. Added to Custom Quant Screener TodayRisk Managed Trade Playbook Analysis - beatles.ru
GYRE THERAPEUTICS, INC. SEC 10-Q Report - TradingView
Can you recover from losses in Gyre Therapeutics Inc.Free Reliable Investment Entry Point Signals - Newser
Gyre Therapeutics' Q2 revenue misses estimates - MarketScreener
Gyre Therapeutics Hits Major Milestone: Phase 3 Liver Drug Success Powers $128M Revenue Outlook - Stock Titan
Sector Rotation Brings Gyre Therapeutics Inc. Into FocusTriple Return Setup With Risk Control Explained - beatles.ru
Published on: 2025-08-11 05:27:12 - Newser
Why Gyre Therapeutics Inc. stock attracts strong analyst attentionReal-Time Entry Signals for Top Stocks - Newser
Gyre Therapeutics Inc (GYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Gyre Therapeutics Inc 주식 (GYRE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ma Songjiang | President |
May 28 '25 |
Sale |
10.07 |
558 |
5,619 |
2,806,084 |
| Ma Songjiang | President |
May 22 '25 |
Sale |
10.97 |
2,000 |
21,940 |
2,808,824 |
| Ma Songjiang | President |
May 23 '25 |
Sale |
10.24 |
182 |
1,864 |
2,808,642 |
| Ma Songjiang | President |
May 20 '25 |
Sale |
11.25 |
2,000 |
22,500 |
2,812,824 |
| Ma Songjiang | President |
May 21 '25 |
Sale |
10.83 |
2,000 |
21,660 |
2,810,824 |
| Ma Songjiang | President |
May 16 '25 |
Sale |
11.31 |
2,000 |
22,620 |
2,816,824 |
| Ma Songjiang | President |
May 19 '25 |
Sale |
11.11 |
2,000 |
22,220 |
2,814,824 |
| Ma Songjiang | President |
May 15 '25 |
Sale |
10.68 |
2,000 |
21,360 |
2,818,824 |
| Ma Songjiang | President |
May 14 '25 |
Sale |
11.30 |
20 |
226 |
2,820,824 |
| Ye Weiguo | Chief Operating Officer |
Apr 01 '25 |
Option Exercise |
0.75 |
50,000 |
37,500 |
700,000 |
0.41%
0.88%
자본화:
|
볼륨(24시간):